![Cytochrome P450 inhibition by three licorice species and fourteen licorice constituents - ScienceDirect Cytochrome P450 inhibition by three licorice species and fourteen licorice constituents - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0928098717304335-fx1.jpg)
Cytochrome P450 inhibition by three licorice species and fourteen licorice constituents - ScienceDirect
![Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation - ScienceDirect Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0163725813000065-gr2.jpg)
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation - ScienceDirect
![Structure of bupropion and hydroxybupropion (major active metabolite). | Download Scientific Diagram Structure of bupropion and hydroxybupropion (major active metabolite). | Download Scientific Diagram](https://www.researchgate.net/publication/51686948/figure/fig1/AS:333012731482112@1456407831039/Structure-of-bupropion-and-hydroxybupropion-major-active-metabolite.png)
Structure of bupropion and hydroxybupropion (major active metabolite). | Download Scientific Diagram
![PDF] Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. | Semantic Scholar PDF] Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e830cc3d701fd6e5ab2d24504894bcd89d3c788b/4-Figure2-1.png)
PDF] Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. | Semantic Scholar
![PDF] Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. | Semantic Scholar PDF] Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e830cc3d701fd6e5ab2d24504894bcd89d3c788b/5-Figure5-1.png)
PDF] Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. | Semantic Scholar
![Cytochrome P450 and Non–Cytochrome P450 Oxidative Metabolism: Contributions to the Pharmacokinetics, Safety, and Efficacy of Xenobiotics | Drug Metabolism & Disposition Cytochrome P450 and Non–Cytochrome P450 Oxidative Metabolism: Contributions to the Pharmacokinetics, Safety, and Efficacy of Xenobiotics | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/sites/default/files/highwire/dmd/44/8.cover-source.jpg)
Cytochrome P450 and Non–Cytochrome P450 Oxidative Metabolism: Contributions to the Pharmacokinetics, Safety, and Efficacy of Xenobiotics | Drug Metabolism & Disposition
![PDF] Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. | Semantic Scholar PDF] Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e830cc3d701fd6e5ab2d24504894bcd89d3c788b/7-Table2-1.png)
PDF] Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. | Semantic Scholar
![Subtherapeutic bupropion and hydroxybupropion serum concentrations in a patient with CYP2C19*1/*17 genotype suggesting a rapid metabolizer status | The Pharmacogenomics Journal Subtherapeutic bupropion and hydroxybupropion serum concentrations in a patient with CYP2C19*1/*17 genotype suggesting a rapid metabolizer status | The Pharmacogenomics Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41397-020-0169-y/MediaObjects/41397_2020_169_Fig1_HTML.png)
Subtherapeutic bupropion and hydroxybupropion serum concentrations in a patient with CYP2C19*1/*17 genotype suggesting a rapid metabolizer status | The Pharmacogenomics Journal
![PDF] Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. | Semantic Scholar PDF] Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e830cc3d701fd6e5ab2d24504894bcd89d3c788b/3-Figure1-1.png)
PDF] Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. | Semantic Scholar
![PDF] Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. | Semantic Scholar PDF] Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e830cc3d701fd6e5ab2d24504894bcd89d3c788b/6-Table1-1.png)
PDF] Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. | Semantic Scholar
![Validation of Bupropion Hydroxylation as a Selective Marker of Human Cytochrome P450 2B6 Catalytic Activity | Drug Metabolism & Disposition Validation of Bupropion Hydroxylation as a Selective Marker of Human Cytochrome P450 2B6 Catalytic Activity | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/content/dmd/28/10/1222/F1.large.jpg)
Validation of Bupropion Hydroxylation as a Selective Marker of Human Cytochrome P450 2B6 Catalytic Activity | Drug Metabolism & Disposition
![Evaluation of the Contribution of Cytochrome P450 3A4 to Human Liver Microsomal Bupropion Hydroxylation | Drug Metabolism & Disposition Evaluation of the Contribution of Cytochrome P450 3A4 to Human Liver Microsomal Bupropion Hydroxylation | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/content/dmd/29/8/1123/F1.large.jpg)
Evaluation of the Contribution of Cytochrome P450 3A4 to Human Liver Microsomal Bupropion Hydroxylation | Drug Metabolism & Disposition
![Frontiers | The Ontogeny of Cytochrome P450 Enzyme Activity and Protein Abundance in Conventional Pigs in Support of Preclinical Pediatric Drug Research Frontiers | The Ontogeny of Cytochrome P450 Enzyme Activity and Protein Abundance in Conventional Pigs in Support of Preclinical Pediatric Drug Research](https://www.frontiersin.org/files/Articles/370394/fphar-09-00470-HTML/image_m/fphar-09-00470-g001.jpg)
Frontiers | The Ontogeny of Cytochrome P450 Enzyme Activity and Protein Abundance in Conventional Pigs in Support of Preclinical Pediatric Drug Research
![PDF] Evaluation of the contribution of cytochrome P450 3A4 to human liver microsomal bupropion hydroxylation. | Semantic Scholar PDF] Evaluation of the contribution of cytochrome P450 3A4 to human liver microsomal bupropion hydroxylation. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/00cb2429b59c5f09510713f2a4e452d174f48153/3-Figure2-1.png)
PDF] Evaluation of the contribution of cytochrome P450 3A4 to human liver microsomal bupropion hydroxylation. | Semantic Scholar
![Frontiers | CYP450 Genotype—Phenotype Concordance Using the Geneva Micrococktail in a Clinical Setting Frontiers | CYP450 Genotype—Phenotype Concordance Using the Geneva Micrococktail in a Clinical Setting](https://www.frontiersin.org/files/MyHome%20Article%20Library/730637/730637_Thumb_400.jpg)
Frontiers | CYP450 Genotype—Phenotype Concordance Using the Geneva Micrococktail in a Clinical Setting
![CYP2B6 allelic variants and non-genetic factors influence CYP2B6 enzyme function | Scientific Reports CYP2B6 allelic variants and non-genetic factors influence CYP2B6 enzyme function | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-022-07022-9/MediaObjects/41598_2022_7022_Fig1_HTML.png)
CYP2B6 allelic variants and non-genetic factors influence CYP2B6 enzyme function | Scientific Reports
![Design and Characterization of the First Selective and Potent Mechanism-Based Inhibitor of Cytochrome P450 4Z1 | Journal of Medicinal Chemistry Design and Characterization of the First Selective and Potent Mechanism-Based Inhibitor of Cytochrome P450 4Z1 | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.0c00101/asset/images/large/jm0c00101_0008.jpeg)
Design and Characterization of the First Selective and Potent Mechanism-Based Inhibitor of Cytochrome P450 4Z1 | Journal of Medicinal Chemistry
![Biotransformation, Using Recombinant CYP450-Expressing Baker's Yeast Cells, Identifies a Novel CYP2D6.10A122V Variant Which Is a Superior Metabolizer of Codeine to Morphine Than the Wild-Type Enzyme | ACS Omega Biotransformation, Using Recombinant CYP450-Expressing Baker's Yeast Cells, Identifies a Novel CYP2D6.10A122V Variant Which Is a Superior Metabolizer of Codeine to Morphine Than the Wild-Type Enzyme | ACS Omega](https://pubs.acs.org/cms/10.1021/acsomega.8b00809/asset/images/large/ao-2018-00809j_0006.jpeg)
Biotransformation, Using Recombinant CYP450-Expressing Baker's Yeast Cells, Identifies a Novel CYP2D6.10A122V Variant Which Is a Superior Metabolizer of Codeine to Morphine Than the Wild-Type Enzyme | ACS Omega
Influence of Various Polymorphic Variants of Cytochrome P450 Oxidoreductase (POR) on Drug Metabolic Activity of CYP3A4 and CYP2B6 | PLOS ONE
![Characterization of furathiocarb metabolism in in-vitro human liver microsomes and recombinant cytochrome P450 enzymes - ScienceDirect Characterization of furathiocarb metabolism in in-vitro human liver microsomes and recombinant cytochrome P450 enzymes - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2214750022000762-ga1.jpg)
Characterization of furathiocarb metabolism in in-vitro human liver microsomes and recombinant cytochrome P450 enzymes - ScienceDirect
![Stereoselective Bupropion Hydroxylation by Cytochrome P450 CYP2B6 and Cytochrome P450 Oxidoreductase Genetic Variants | Drug Metabolism & Disposition Stereoselective Bupropion Hydroxylation by Cytochrome P450 CYP2B6 and Cytochrome P450 Oxidoreductase Genetic Variants | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/content/dmd/48/6/438/F1.large.jpg)